FDA-Inspected Site

Primo Medical Group

4 FDA inspections are on record for Primo Medical Group in Stoughton, United States.

Clean· No action indicated

Stoughton, United States · Last updated July 10, 2026

Overview

  • 4 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2019-10-03.

At a glance

Inspections

4

Form 483s

2

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
2 Oct 2019 – 3 Oct 2019Medical Devices & Rad HealthClean
22 Jul 2015 – 27 Jul 2015Medical Devices & Rad Health483View 483 →
18 Feb 2011Not recorded483View 483 →
6 Nov 2009Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

27 Jul 2015
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by David J Feria

27 Jul 2015
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by David J Feria

27 Jul 2015
21 CFR 820.25(b)

Training

Cited by David J Feria

27 Jul 2015
21 CFR 820.70(c)

Environmental control Lack of or inadequate procedures

Cited by David J Feria

18 Feb 2011
21 CFR 820.75(b)(2)

Documentation of validated process performance

Cited by Maura Rooney

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.25(b)Cited across public-safe Form 483 observations1x
21 CFR 820.70(c)Cited across public-safe Form 483 observations1x
21 CFR 820.75(b)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Primo Medical Group's 2 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat